These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [DIFFERENTIATION BETWEEN ACID-RESISTANT SAPROPHYTES, MYCOBACTERIUM TUBERCULOSIS AND ATYPICAL STRAINS BY THE DETERMINATION OF FORMAMIDASE ACTIVITY]. DYKHNO MM; ZEMTSOVA OM; ZAIDES VM Probl Tuberk; 1964; 42():63-6. PubMed ID: 14246873 [No Abstract] [Full Text] [Related]
23. THE IMMUNOGENICITY OF BCG (PHIPPS) AND ITS ISONIAZID-RESISTANT MUTANT IN GUINEA PIGS SIMULTANEOUSLY VACCINATED, INFECTED, AND TREATED. DWORSKI M Am Rev Respir Dis; 1964 Jul; 90():97-104. PubMed ID: 14180060 [No Abstract] [Full Text] [Related]
24. The influence of remaining live BCG organisms in vaccinated mice on the maintenance of immunity to tuberculosis. Olsen AW; Brandt L; Agger EM; van Pinxteren LA; Andersen P Scand J Immunol; 2004 Sep; 60(3):273-7. PubMed ID: 15320884 [TBL] [Abstract][Full Text] [Related]
25. [COMPARATIVE STUDY OF THE PROTECTIVE POWER OF ORAL BCG IN WHITE AND BROWN MICE]. LOPES EA; FERREIRA OT Hospital (Rio J); 1963 Nov; 64():1075-85. PubMed ID: 14126184 [No Abstract] [Full Text] [Related]
26. FORMAMIDASE ACTIVITY OF MYCOBACTERIA. I. SIGNIFICANCE AS A MARKER FOR DIFFERENTIATING MYCOBACTERIA. URABE K; TAKEI N; SAITO H Am Rev Respir Dis; 1965 Jan; 91():120-4. PubMed ID: 14259994 [No Abstract] [Full Text] [Related]
27. [Relation between protection by BCG vaccination and the antibacterial action of isoniazid in tubercular infections obtained in mice by means of mycobacteria labeled with C-14 radiocarbon]. MAURO B; PASQUIER JF Ann Ist Carlo Forlanini; 1961; 21():67-73. PubMed ID: 14471589 [No Abstract] [Full Text] [Related]
28. [Current data on antituberculous immunity and on BCG vaccination]. SAENZ A Sem Hop Ther Paris; 1962 Oct; 38():713-21. PubMed ID: 13976010 [No Abstract] [Full Text] [Related]
29. [The genetic regulation of host response to inoculation with Mycobacterium bovis (BCG) and Mycobacterium tuberculosis H37RV]. Nikonenko BV; Mezhlumova MB; Moroz AM Biull Eksp Biol Med; 1990 Nov; 110(11):526-8. PubMed ID: 2128037 [TBL] [Abstract][Full Text] [Related]
30. [TRANSFER OF IMMUNITY TO TUBERCULOSIS BY MEANS OF CELLS FROM BCG VACCINATED MICE. 1. ON THE EFFECT OF TRANSFERRED CELLS IN 2 MOUSE STRAINS DIFFERING IN SUSCEPTIBILITY TO TUBERCULOSIS]. ASABA G; NAGATOMI H; WATABIKI S; FUKAZAWA Y; AKIYAMA T; MAEDA K Kekkaku; 1964 Feb; 39():55-9. PubMed ID: 14136875 [No Abstract] [Full Text] [Related]
31. [Immunity and tuberculosis]. WALLGREN A Lotta Tuberc; 1952 Dec; 22(12):931-49. PubMed ID: 13053895 [No Abstract] [Full Text] [Related]
32. ACQUIRED IMMUNITY TO TUBERCULOSIS. HART PD; SUTHERLAND I Am Rev Respir Dis; 1965 Jun; 91():939. PubMed ID: 14294721 [No Abstract] [Full Text] [Related]
33. IMMUNITY TO TUBERCULOSIS AS REVEALED FROM STUDIES OF TUBERCULOSIS IN NURSES. BADGER TL J Lancet; 1965 Feb; 85():84-90. PubMed ID: 14270652 [No Abstract] [Full Text] [Related]
34. ACQUIRED RESISTANCE TO TUBERCULOSIS INDUCED IN RED MICE (CLETHRIONOMYS G. GLAREOLUS SCHREB.) BY VACCINATION WITH LIVING BCG. 2. DETERMINATION OF DOSAGE RANGE FOR CHALLENGE. JESPERSEN A; BENTZON MW Acta Pathol Microbiol Scand; 1963; 59():383-99. PubMed ID: 14064819 [No Abstract] [Full Text] [Related]
35. [DIFFERENTIATION OF BOVINE AND AVIAN MYCOBACTERIA BY THE DETERMINATION OF NICOTINE-AND ISONICOTINAMIDASE ACTIVITY. (SHORT AMIDASE GROUP)]. HOCMANOVA M; KRCMERY V Cesk Epidemiol Mikrobiol Imunol; 1964 Jul; 13():241-3. PubMed ID: 14188497 [No Abstract] [Full Text] [Related]
36. [EFFECT OF LARGE DOSES OF CAFFEINE ON THE FORMATION OF IMMUNITY TO TUBERCULOSIS IN VACCINATED WHITE MICE]. PERELMAN AE Biull Eksp Biol Med; 1964 Sep; 58():102-6. PubMed ID: 14273444 [No Abstract] [Full Text] [Related]
37. [Histo-immunological dynamics of local lymphoreticular and mesenchymal tissue in BCG vaccination and in experimental tuberculosis reinfection]. LENZINI L; BARNABE R; SBRAGIA S Gazz Int Med Chir; 1963 Mar; 67():481-521. PubMed ID: 13929680 [No Abstract] [Full Text] [Related]
39. Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy. Lu M; Xia ZY; Bao L Cell Immunol; 2013; 285(1-2):111-7. PubMed ID: 24177251 [TBL] [Abstract][Full Text] [Related]
40. [USE OF BCG VACCINATION OR A PUBLIC TUBERCULIN REGISTER]. KREUSER F Offentl Gesundheitsdienst; 1964; 26():228-32. PubMed ID: 14214675 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]